Tissue kallikrein for the treatment of diseases associated with amyloid protein

Details for Australian Patent Application No. 2008280782 (hide)

Owner Genesys Venture Inc.

Inventors Williams, Mark

Agent Davies Collison Cave

Pub. Number AU-A-2008280782

PCT Pub. Number WO2009/012571

Priority 61/056,411 27.05.08 US; 61/061,322 13.06.08 US; 60/950,960 20.07.07 US; 61/023,505 25.01.08 US

Filing date 18 July 2008

Wipo publication date 29 January 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 31/00 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/012571 Priority application(s): WO2009/012571

29 April 2010 Assignment before Grant

  Genesys Venture Inc. The application has been assigned to Sanomune Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008280784-Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta9 desaturase

2008280780-Treating or ameliorating a neuromflammatory or demyelimating disorder with prolactin and interferon-beta